Cost of common treatments could rise sevenfold with a Johnson/Trump Trade Deal - The Insider

Cost of common treatments could rise sevenfold with a Johnson/Trump Trade Deal

Last night’s Dispatches on Channel 4 showed that despite what Boris Johnson and his Ministers are saying publicly, the NHS is firmly on the table in trade talks with Trump.

President Trump and senior members of his cabinet have stated their intention to use trade deals to end “foreign freeloading” on drug prices and push up prices to bring them closer to US levels. This is why research carried out for Dispatches suggested a trade deal with the US could cost the NHS £27 billion as drug prices soar.

Labour analysis of research by the same academics looked at how this could impact specific drugs, with the cost of some common treatments rising sevenfold.

The table below shows how costs could soar for 20 of the most common prescription medicines:

Analysis of price multipliers by academics at the University of Liverpool on behalf of Reuters
NHS indicative price as listed the British National Formulary published by
NICE

It’s clear you can’t trust the Tories with the NHS.

Related Articles

Read more

Revealed: Boris Johnson’s customs declaration plan to cost business the equivalent of over 400,000 jobs

read more  
Read more

Why you can’t trust the Tories with workers’ rights

read more